Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Article
  • Published:

PUMA-G and HM74 are receptors for nicotinic acid and mediate its anti-lipolytic effect

This article has been updated

Abstract

Nicotinic acid (niacin), a vitamin of the B complex, has been used for almost 50 years as a lipid-lowering drug1,2. The pharmacological effect of nicotinic acid requires doses that are much higher than those provided by a normal diet3,4. Its primary action is to decrease lipolysis in adipose tissue by inhibiting hormone-sensitive triglyceride lipase5. This anti-lipolytic effect of nicotinic acid involves the inhibition of cyclic adenosine monophosphate (cAMP) accumulation in adipose tissue6 through a Gi-protein-mediated inhibition of adenylyl cyclase7,8,9. A G-protein-coupled receptor for nicotinic acid has been proposed in adipocytes10,11. Here, we show that the orphan G-protein-coupled receptor, 'protein upregulated in macrophages by interferon-γ' (mouse PUMA-G, human HM74)12,13, is highly expressed in adipose tissue and is a nicotinic acid receptor. Binding of nicotinic acid to PUMA-G or HM74 results in a Gi-mediated decrease in cAMP levels. In mice lacking PUMA-G, the nicotinic acid–induced decrease in free fatty acid (FFA) and triglyceride plasma levels was abrogated, indicating that PUMA-G mediates the anti-lipolytic and lipid-lowering effects of nicotinic acid in vivo. The identification of the nicotinic acid receptor may be useful in the development of new drugs to treat dyslipidemia.

NOTE: In the version of this article initially published online, the statements concerning equal author contribution and corresponding authors were incorrect. This mistake has been corrected for the HTML and print versions of the article.

This is a preview of subscription content, access via your institution

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

Figure 1: PUMA-G and HM74 expression in adipose tissue.
Figure 2: PUMA-G and HM74 are Gi-coupled receptors for nicotinic acid and related compounds.
Figure 3: Generation and analysis of PUMA-G-deficient mice.

Similar content being viewed by others

Accession codes

Accessions

GenBank/EMBL/DDBJ

Change history

  • 10 February 2003

    This was incorrect in AOP version but corrected in print. Changed Klaus Pfeffer to be a corresponding author as per note.

References

  1. Knopp, R.H. Drug treatment of lipid disorders N. Engl. J. Med. 341, 498–511 (1999).

    Article  CAS  Google Scholar 

  2. Szapary, P.O. & Rader, D.J. Pharmacological management of high triglycerides and low high-density lipoprotein cholesterol. Curr. Opin. Pharmacol. 1, 113–120 (2001).

    Article  CAS  Google Scholar 

  3. Hotz, W. Nicotinic acid and its derivatives: a short survey. Adv. Lipid. Res. 20, 195–217 (1983).

    CAS  PubMed  Google Scholar 

  4. Olsson, A.G. Nicotinic acid and derivatives. In Handbook of Experimental Pharmacology vol. 109 (eds. Schettler, G. & Habenicht, A.J.R.) 349–400 (Springer-Verlag, Heidelberg, 1994).

    Google Scholar 

  5. Carlson, L.A. Studies on the effect of nicotinic acid on catecholamine-stimulated lipolysis in adipose tissue in vitro. Acta Med. Scand. 173, 719 (1963).

    Article  CAS  Google Scholar 

  6. Butcher, R.W., Baird, C.E. & Sutherland, E.W. Effects of lipolytic and antilipolytic substances on adenosine 3′,5′-monophosphate levels in isolated fat cells. J. Biol. Chem. 243, 17005–17012 (1968).

    Google Scholar 

  7. Aktories, K., Schultz, G. & Jakobs, K.H. Regulation of adenylate cyclase activity in hamster adipocytes. Inhibition by prostaglandins, α-adrenergic agonists and nicotinic acid. Naunyn Schmiedebergs Arch. Pharmacol. 312, 167–173 (1980a).

    Article  CAS  Google Scholar 

  8. Fredholm, B.B. Adenosine and lipolysis. Int. J. Obes. 5, 643–649 (1981).

    CAS  PubMed  Google Scholar 

  9. Aktories, K., Schultz, G. & Jakobs K.H. Inactivation of the guanine nucleotide regulatory site mediating inhibition of the adenylate cyclase in hamster adipocytes. Naunyn Schmiedebergs Arch Pharmacol. 321, 247–252 (1982).

    Article  CAS  Google Scholar 

  10. Aktories, K., Jakobs, K.H. & Schultz, G. Nicotinic acid inhibits adipocyte adenylate cyclase in a hormone-like manner. FEBS Lett. 115, 11–14 (1980b).

    Article  CAS  Google Scholar 

  11. Lorenzen, A. et al. Characterization of a G protein-coupled receptor for nicotinic acid. Mol. Pharmacol. 59, 349–357 (2001).

    Article  CAS  Google Scholar 

  12. Nomura, H., Nielsen, B.W. & Matsushima, K. Molecular cloning of cDNAs encoding a LD78 receptor and putative leukocyte chemotactic peptide receptors. Int. Immunol. 5, 1239–1249 (1993).

    Article  CAS  Google Scholar 

  13. Schaub, A., Futterer, A. & Pfeffer, K. PUMA-G, an IFN-γ-inducible gene in macrophages is a novel member of the seven transmembrane spanning receptor superfamily. Eur. J. Immunol. 31, 3714–3725 (2001).

    Article  CAS  Google Scholar 

  14. Lorenzen, A., Stannek, C., Burmeister, A., Kalvinsh, I. & Schwabe, U. G protein-coupled receptor for nicotinic acid in mouse macrophages. Biochem. Pharmacol. 64, 645–648 (2002).

    Article  CAS  Google Scholar 

  15. Yousefi, S., Cooper, P.R., Mueck, B., Potter, S.L. & Jarai, G. cDNA representational difference analysis of human neutrophils stimulated by GM-CSF. Biochem. Biophys. Res. Commun. 277, 401–409 (2000).

    Article  CAS  Google Scholar 

  16. Offermanns, S. & Simon, M.I. Gα15 and Gα16 couple a wide variety of receptors to phospholipase C. J. Biol. Chem. 270, 15175–15180 (1995).

    Article  CAS  Google Scholar 

  17. Baubet, V. et al. Chimeric green fluorescent protein-aequorin as bioluminescent Ca2+ reporters at the single-cell level. Proc. Natl. Acad. Sci. USA 97, 7260–7265 (2000).

    Article  CAS  Google Scholar 

  18. Aktories, K., Schultz, G. & Jakobs, K.H. Inhibition of adenylate cyclase and stimulation of a high affinity GTPase by the antilipolytic agents, nicotinic acid, acipimox and various related compounds. Arzneimittelforschung 33, 1525–1527 (1983).

    CAS  PubMed  Google Scholar 

  19. Rudolph, U., Spicher, K. & Birnbaumer, L. Adenylyl cyclase inhibition and altered G protein subunit expression and ADP-ribosylation patterns in tissues and cells from Gi2α−/− mice. Proc. Natl. Acad. Sci. USA 93, 3209–3214 (1996).

    Article  CAS  Google Scholar 

  20. Kather, H., Aktories, K., Schulz, G. & Jakobs, K.H. Islet-activating protein discriminates the antilipolytic mechanism of insulin from that of other antilipolytic compounds. FEBS Lett. 161, 149–152 (1983).

    Article  CAS  Google Scholar 

  21. Svedmyr, N., Harthon, L. & Lundholm, L. The relationship between the plasma concentration of free nicotinic acid and some of its pharmacologic effects in man. Clin. Pharmacol. Ther. 10, 559–570 (1969).

    Article  CAS  Google Scholar 

  22. Carlson, L.A., Oro, L. & Ostman, J, Effect of a single dose of nicotinic acid on plasma lipids in patients with hyperlipoproteinemia. Acta Med. Scand. 183, 457–465 (1968).

    Article  CAS  Google Scholar 

  23. Geigy Scientific Tables vol. 3 (ed. Lentner, C.) 129 (Ciba-Geigy, Basle, Switzerland, 1984).

  24. Hosoi, T. et al. Identification of a novel human eicosanoid receptor coupled to Gi/o . J. Biol. Chem. 277, 31459–31465 (2002).

    Article  CAS  Google Scholar 

  25. Rodbell, M. Metabolism of isolated fat cells. J. Biol. Chem. 239, 375–380 (1964).

    CAS  PubMed  Google Scholar 

Download references

Acknowledgements

The authors wish to thank A. Fütterer, J. Meinecke, K. Meyer, K. Mink, E. Schaller and B. Wallenwein for technical assistance and G. Scholze and W. Fiehn for help with triglyceride determinations. J.K. received a fellowship from the Serono Foundation. This work was supported by the Deutsche Forschungsgemeinschaft.

Author information

Authors and Affiliations

Authors

Corresponding authors

Correspondence to Klaus Pfeffer or Stefan Offermanns.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Supplementary information

Rights and permissions

Reprints and permissions

About this article

Cite this article

Tunaru, S., Kero, J., Schaub, A. et al. PUMA-G and HM74 are receptors for nicotinic acid and mediate its anti-lipolytic effect. Nat Med 9, 352–355 (2003). https://doi.org/10.1038/nm824

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nm824

This article is cited by

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing